Latest filing published 10 Oct 2017 for SELLAS Life Sciences Group, Inc., €6,753.
Insider track record
Sanford Hillsberg: trading record in brief
Sanford Hillsberg has filed trades across 3 companies (mainly through SEC (Form 4)), most often in Duska Therapeutics, Inc., SELLAS Life Sciences Group, Inc. and Iovance Biotherapeutics, Inc. In total, 64 filings cover trades dated from 30 May 2006 to 10 October 2017.
The open-market record consists of 39 sales worth €3.9M, with no purchase. The rest of the record consists of 16 share grants and 4 option exercises.
On 10 October 2017 came the latest disclosure, a share grant for €6,753 in SELLAS Life Sciences Group, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Sanford Hillsberg
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,997 shares@ US$0.3823.7% of flowCommon StockSEC:0001394548-17-000031:0
- 13,390 shares@ US$0.5924.2% of flowCommon StockSEC:0001394548-17-000023:0
- 13,394 shares@ US$0.5926.1% of flowCommon StockSEC:0001394548-17-000016:0
- 3,998 shares@ US$1.9826.0% of flowCommon StockSEC:0001394548-17-000007:0
- 33,500 shares@ US$9.1031.3% of flowCommon StockSEC:0001250853-16-000172:0
- 20,500 shares@ US$8.7118.3% of flowCommon StockSEC:0001250853-16-000172:1
- 54,000 shares@ US$9.1150.3% of flowCommon StockSEC:0001250853-16-000171:0
- 16,000 shares@ US$6.84Common StockSEC:0001250853-15-000090:0
- 16,500 shares@ US$7.13Common StockSEC:0001250853-15-000090:1
- 32,500 shares@ US$8.15Common StockSEC:0001250853-15-000084:0
- 50,000 shares@ US$10.00Common StockSEC:0001250853-15-000038:0
- 25,000 shares0Common StockSEC:0001250853-15-000019:0
- 25,000 shares0Common StockSEC:0001250853-15-000019:1
- 15,000 shares0Common StockSEC:0001250853-14-000040:3
- 200,000 shares@ US$1.18Common StockSEC:0001250853-14-000040:0
- 50,000 shares@ US$1.71Common StockSEC:0001250853-14-000040:1
- 250,000 shares@ US$5.41Common StockSEC:0001250853-14-000040:2
- 200,000 shares@ US$6.93Common StockSEC:0001250853-14-000027:0
- 200,000 shares@ US$0.85Common StockSEC:0001250853-14-000020:0
- 24,426 shares@ US$6.96Common StockSEC:0001250853-14-000020:1
- 67,500 sharesCommon StockSEC:0001250853-14-000019:0
- 37,001 shares0Common StockSEC:0001250853-13-000151:0
- 50,000 shares@ US$0.72Common StockSEC:0001250853-13-000151:1
- 8,592 shares@ US$4.19Common StockSEC:0001250853-13-000151:2
- 67,500 sharesCommon StockSEC:0001250853-13-000110:0
25 of 61 declarations
